Literature DB >> 16731431

Standards for performing DXA in individuals with secondary causes of osteoporosis.

Aliya A Khan1, David A Hanley, John P Bilezikian, Neil Binkley, Jacques P Brown, Anthony B Hodsman, Robert G Josse, David L Kendler, E Michael Lewiecki, Paul D Miller, Wojciech P Olszynski, Steven M Petak, Zeba A Syed, Diane Theriault, Nelson B Watts.   

Abstract

This document addresses skeletal health assessment in individuals with secondary causes of osteoporosis. Recommendations are based on consensus of the Canadian Panel of the International Society for Clinical Densitometry and invited international experts. Bone mineral density (BMD) testing in these populations is performed in conjunction with careful evaluation of the disease state contributing to bone loss and increased fragility fracture risk, as well as assessment of other contributing risk factors for fracture. The presence of secondary causes of bone loss may further increase the risk of fracture independently of BMD and may necessitate earlier pharmacologic intervention. Dual-energy X-ray absorptiometry is indicated in the initial workup of secondary causes of osteoporosis. The BMD fracture risk relationship is not known for individuals with chronic renal failure (CRF). The BMD testing in this population may be normal in the presence of skeletal fragility, and quantitative bone histomorphometry is better at evaluating skeletal status than BMD in CRF. Dual-energy X-ray absorptiometry is a valuable tool in assessing skeletal health in individuals with secondary causes of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731431     DOI: 10.1016/j.jocd.2006.01.001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  8 in total

1.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

2.  What is adequate?

Authors:  Adrian B Jones
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

3.  Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients.

Authors:  Africa Muxí; José-Vicente Torregrosa; David Fuster; Pilar Peris; Sergi Vidal-Sicart; Oriol Solá; Beatriz Domenech; Gloria Martín; Joan Casellas; Francisca Pons
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

4.  Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency.

Authors:  Gherardo Mazziotti; Antonio Bianchi; Vincenzo Cimino; Stefania Bonadonna; Paola Martini; Alessandra Fusco; Laura De Marinis; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 5.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 6.  The female football player, disordered eating, menstrual function and bone health.

Authors:  Jorunn Sundgot-Borgen; Monica Klungland Torstveit
Journal:  Br J Sports Med       Date:  2007-07-03       Impact factor: 13.800

7.  The female athlete triad.

Authors:  Taraneh Gharib Nazem; Kathryn E Ackerman
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

8.  Cancer treatment-related bone loss: a review and synthesis of the literature.

Authors:  M N Khan; A A Khan
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.